2 datasets found
  1. Table_1_Gastric cancer clinical characteristics and their altered trends in...

    • frontiersin.figshare.com
    • datasetcatalog.nlm.nih.gov
    docx
    Updated Jun 21, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Hongfa Wei; Xiao-Yong Zhan; Xianying Liao; Wenchao Li; Hui Chen; Cuncan Deng; Xinghan Jin; Zhangsen Huang; Mo Yang; Changhua Zhang; Yulong He (2023). Table_1_Gastric cancer clinical characteristics and their altered trends in South China: An epidemiological study with 2,800 cases spanning 26 years.docx [Dataset]. http://doi.org/10.3389/fonc.2023.976854.s004
    Explore at:
    docxAvailable download formats
    Dataset updated
    Jun 21, 2023
    Dataset provided by
    Frontiers Mediahttp://www.frontiersin.org/
    Authors
    Hongfa Wei; Xiao-Yong Zhan; Xianying Liao; Wenchao Li; Hui Chen; Cuncan Deng; Xinghan Jin; Zhangsen Huang; Mo Yang; Changhua Zhang; Yulong He
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    BackgroundGastric cancer (GC) is a serious threat to human health. The clinical GC characteristics in China may be impacted by changes in people’s lifestyles and the promotion of early GC (EGC) screening. The present study aims to evaluate the recent trends of GC characteristics in South China and search for hazardous factors limiting the survival time of GC patients.MethodsData on GC patients that were hospitalized in the Department of Digestive Center, the First Affiliated Hospital, Sun Yat-sen University, from 1994 to 2019 were collected and divided into two categories according to the time when the EGC screening began in China: the PRE group (previous 13 years, 1994–2006) and the PAS group (past 13 years, 2007–2019).ResultsWe found that, although the 5-year survival rate increased in the PAS group compared with the PRE group (P < 0.0001), patients with age ≥60 years or Borrmann type IV still had a worse prognosis. In the PAS group, the larger percentages of elderly patients and patients with Borrmann type IV in the lymphatic metastases (N1) group (41.0% vs. 51.1%, P = 0.0014) and stage IV subgroup (20.7% vs. 32.2%, P = 0.016), respectively, when compared with the PRE group, may have contributed to the poor outcome of GC. By comparing the odds ratio (OR) of 5-year overall survival (OS) in the two 13-year periods, female sex and T2 turned into risk factors because of a greater proportion of Borrmann type IV or elderly patients in the PAS group (OR = 0.983, 95% CI = 0.723–1.336 vs. OR = 1.277, 95% CI = 1.028–1.586 and OR = 1.545, 95% CI = 0.499–4.775 vs. OR = 2.227, 95% CI = 1.124–4.271, respectively).ConclusionsDespite the GC epidemiology changes, the overall prognosis of GC patients has improved in South China. However, old age and Borrmann type IV are still the major restrictions affecting the survival of GC patients, a situation which calls for additional attention.

  2. 新西兰 出口:离岸价:中国:趋势

    • ceicdata.com
    Updated Jan 15, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    CEICdata.com (2025). 新西兰 出口:离岸价:中国:趋势 [Dataset]. https://www.ceicdata.com/zh-hans/new-zealand/exports-by-country/exports-fob-china-trend
    Explore at:
    Dataset updated
    Jan 15, 2025
    Dataset provided by
    CEICdata.com
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Time period covered
    Feb 1, 2024 - Jan 1, 2025
    Area covered
    新西兰
    Variables measured
    Merchandise Trade
    Description

    出口:离岸价:中国:趋势在03-01-2025达1,784.343百万新西兰元,相较于02-01-2025的1,762.889百万新西兰元有所增长。出口:离岸价:中国:趋势数据按月更新,07-01-1981至03-01-2025期间平均值为124.295百万新西兰元,共525份观测结果。该数据的历史最高值出现于08-01-2022,达1,795.120百万新西兰元,而历史最低值则出现于04-01-1982,为8.678百万新西兰元。CEIC提供的出口:离岸价:中国:趋势数据处于定期更新的状态,数据来源于Stats NZ,数据归类于全球数据库的新西兰 – Table NZ.JA015: Exports: by Country。

  3. Not seeing a result you expected?
    Learn how you can add new datasets to our index.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
Hongfa Wei; Xiao-Yong Zhan; Xianying Liao; Wenchao Li; Hui Chen; Cuncan Deng; Xinghan Jin; Zhangsen Huang; Mo Yang; Changhua Zhang; Yulong He (2023). Table_1_Gastric cancer clinical characteristics and their altered trends in South China: An epidemiological study with 2,800 cases spanning 26 years.docx [Dataset]. http://doi.org/10.3389/fonc.2023.976854.s004
Organization logo

Table_1_Gastric cancer clinical characteristics and their altered trends in South China: An epidemiological study with 2,800 cases spanning 26 years.docx

Related Article
Explore at:
docxAvailable download formats
Dataset updated
Jun 21, 2023
Dataset provided by
Frontiers Mediahttp://www.frontiersin.org/
Authors
Hongfa Wei; Xiao-Yong Zhan; Xianying Liao; Wenchao Li; Hui Chen; Cuncan Deng; Xinghan Jin; Zhangsen Huang; Mo Yang; Changhua Zhang; Yulong He
License

Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically

Description

BackgroundGastric cancer (GC) is a serious threat to human health. The clinical GC characteristics in China may be impacted by changes in people’s lifestyles and the promotion of early GC (EGC) screening. The present study aims to evaluate the recent trends of GC characteristics in South China and search for hazardous factors limiting the survival time of GC patients.MethodsData on GC patients that were hospitalized in the Department of Digestive Center, the First Affiliated Hospital, Sun Yat-sen University, from 1994 to 2019 were collected and divided into two categories according to the time when the EGC screening began in China: the PRE group (previous 13 years, 1994–2006) and the PAS group (past 13 years, 2007–2019).ResultsWe found that, although the 5-year survival rate increased in the PAS group compared with the PRE group (P < 0.0001), patients with age ≥60 years or Borrmann type IV still had a worse prognosis. In the PAS group, the larger percentages of elderly patients and patients with Borrmann type IV in the lymphatic metastases (N1) group (41.0% vs. 51.1%, P = 0.0014) and stage IV subgroup (20.7% vs. 32.2%, P = 0.016), respectively, when compared with the PRE group, may have contributed to the poor outcome of GC. By comparing the odds ratio (OR) of 5-year overall survival (OS) in the two 13-year periods, female sex and T2 turned into risk factors because of a greater proportion of Borrmann type IV or elderly patients in the PAS group (OR = 0.983, 95% CI = 0.723–1.336 vs. OR = 1.277, 95% CI = 1.028–1.586 and OR = 1.545, 95% CI = 0.499–4.775 vs. OR = 2.227, 95% CI = 1.124–4.271, respectively).ConclusionsDespite the GC epidemiology changes, the overall prognosis of GC patients has improved in South China. However, old age and Borrmann type IV are still the major restrictions affecting the survival of GC patients, a situation which calls for additional attention.

Search
Clear search
Close search
Google apps
Main menu